Finance

Lists
1276:HKG
Jiangsu Hengrui Pharmaceuticals Co Ltd
HK$ ४७.६०
-०.८३%
(-०.४०) 1D
अक्टोबर १६, १६:०८:१४ GMT+८  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 1276...
Open
HK$ ४८.००
High
HK$ ४९.३०
Low
HK$ ४६.९२
Mkt. cap
३.४६ खरब
Avg. vol.
४०.४० लाख
Volume
४१.६५ लाख
P/E ratio
३४.८६
52-wk high
HK$ ८४.५०
52-wk low
HK$ ४३.०२
EPS
HK$ १.३७
No. of employees
२१ हजार
Open
HK$ ४८.००
High
HK$ ४९.३०
Low
HK$ ४६.९२
Mkt. cap
३.४६ खरब
Avg. vol.
४०.४० लाख
Volume
४१.६५ लाख
P/E ratio
३४.८६
52-wk high
HK$ ८४.५०
52-wk low
HK$ ४३.०२
EPS
HK$ १.३७
No. of employees
२१ हजार
News stories
From web sources and news partners
Profile
Jiangsu Hengrui Pharmaceuticals Company Ltd., also known as Jiangsu Hengrui, is a Chinese pharmaceutical company that manufactures and distributes various types of drug packaging materials, cancer-treating antineoplastics, cardiovascular medication, painkillers, antibiotics, and related products. It is the largest listed pharmaceutical company in China. Wikipedia
About Jiangsu Hengrui Pharmaceuticals Co Ltd
CEO-
Employees२०.७ हजार
Founded१९७०
Headquarters-
Sector-
Next call ९ दिनमा
अक्टोबर २७, मङ्गल, ०९:००
Fiscal period
Q3 2026
- / CN¥ ०.३१
Revenue / Est. (CNY)
- / ९.१७ अरब
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
७.४३ अरब
८.४४ अरब
८.१४ अरब
७.३२ अरब
Cost of goods sold
१.०७ अरब
१.२५ अरब
१.०९ अरब
१.०२ अरब
Cost of revenue
१.०७ अरब
१.२५ अरब
१.०९ अरब
१.०२ अरब
Research and development expenses
१.७२ अरब
२.०२ अरब
१.६५ अरब
१.८४ अरब
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
३.२३ अरब
३.०१ अरब
२.८१ अरब
२.७८ अरब
Operating expense
४.७६ अरब
५.३५ अरब
४.४८ अरब
४.६१ अरब
Total operating expenses
५.८३ अरब
६.६० अरब
५.५७ अरब
५.६३ अरब
Operating income
१.६० अरब
१.८४ अरब
२.५७ अरब
१.६८ अरब
Other non operating income
-१५.४२ करोड
१४.५७ करोड
-३४.५१ करोड
२४.३९ करोड
EBT including unusual items
१.३६ अरब
२.३० अरब
२.५६ अरब
२.४० अरब
EBT excluding unusual items
१.६८ अरब
१.९१ अरब
२.५५ अरब
१.६० अरब
Income tax expense
५.५५ करोड
३३.८९ करोड
२७.५९ करोड
२१.१३ करोड
Effective tax rate
४.०८%
१४.७६%
१०.७९%
८.८२%
Other operating expenses
-२१.७३ करोड
३२.६८ करोड
४७.५६ लाख
-५०.९२ लाख
Net income
१.३० अरब
१.९६ अरब
२.२८ अरब
२.१८ अरब
Net profit margin
१७.५२%
२३.२२%
२८.०४%
२९.८४%
Earnings per share
०.२०
-
-
-
Interest and investment income
२४.२१ करोड
२८.८७ करोड
३२.३० करोड
४.४८ लाख
Interest expense
-६.९० लाख
-१९.९६ लाख
-४.४८ लाख
-३२.३० करोड
Net interest expenses
२४.१५ करोड
२८.६७ करोड
३२.२५ करोड
-३२.२५ करोड
Depreciation and amortization charges
-
-
-
-
EBITDA
१.७८ अरब
२.०४ अरब
२.७७ अरब
१.९३ अरब
Gain or loss from assets sale
२३.११ लाख
-४०.५३ लाख
-
-४.०६ करोड
AI content may include mistakes. Learn more
Google एपहरू